Abstract

The European Association for Cancer Research (EACR) has the advancement of cancer research as its guiding aim. It was established in 1968 and today is Europe�s largest member society for cancer research. EACR is a founder member of ECCO, the European CanCer Organisation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
ECCO 15: 34th ESMO Multidisciplinary Congress in Berlin: a step forward to a high-quality global oncology forum
Andrés Cervantes
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. 11
Andrés CervantesAndrés Cervantes
01 Oct 2009
The European Cancer Congress 2013 – The Largest Platform for Practice-changing Data in Europe
Catherine Shiels
European Oncology & Haematology | VOL. 09
Catherine ShielsCatherine Shiels
01 Jan 2013
Molecular Oncology and the EACR: new partners in communicating and supporting cancer research.
Kevin M Ryan ... Jane Smith
Molecular oncology | VOL. 17
Kevin M Ryan, et. al.Kevin M Ryan ... Jane Smith
01 Jun 2023
Defense is the Best Attack: Immuno-Oncology Breakthroughs - Third European Association for Cancer Research (EACR) Conference.Virtual - February 16-17, 2021
J Tur
Drugs of The Future | VOL. 46
J TurJ Tur
01 Jan 2020
View more papers

More From: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Paper Title
Journal
Date
Author
The potential value of dual-energy CT radiomics in evaluating CD8+, CD163+ and αSMA+ cells in the tumor microenvironment of clear cell renal cell carcinoma.
Ruobing Li ... Aimei Ouyang
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. -
Ruobing Li, et. al.Ruobing Li ... Aimei Ouyang
31 Jul 2024
Baseline 18F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma with extranodal involvement.
Fenglian Jing ... Jingmian Zhang
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. -
Fenglian Jing, et. al.Fenglian Jing ... Jingmian Zhang
31 Jul 2024
Nomograms for prognosis prediction in esophageal adenocarcinoma: realities and challenges.
Hong Zheng ... Xiangqian Guo
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. -
Hong Zheng, et. al.Hong Zheng ... Xiangqian Guo
31 Jul 2024
PSIP1 promotes gefitinib resistance in lung adenocarcinoma by inducing the expression of WASF3 and its downstream ITGB3/AKT signaling.
Shujun Wu ... Huan Wang
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | VOL. -
Shujun Wu, et. al.Shujun Wu ... Huan Wang
30 Jul 2024
View more papers